199 related articles for article (PubMed ID: 10858191)
1. Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.
Externest D; Meckelein B; Schmidt MA; Frey A
Infect Immun; 2000 Jul; 68(7):3830-9. PubMed ID: 10858191
[TBL] [Abstract][Full Text] [Related]
2. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
[TBL] [Abstract][Full Text] [Related]
3. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Infect Immun; 2000 Oct; 68(10):5749-55. PubMed ID: 10992481
[TBL] [Abstract][Full Text] [Related]
4. Induction of IgA and IgG antibodies in vaginal fluid, serum and saliva following immunization of genital and gut associated lymphoid tissue.
Bergmeier LA; Tao L; Gearing AJ; Adams S; Lehner T
Adv Exp Med Biol; 1995; 371B():1567-73. PubMed ID: 7502858
[TBL] [Abstract][Full Text] [Related]
5. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces.
Haneberg B; Kendall D; Amerongen HM; Apter FM; Kraehenbuhl JP; Neutra MR
Infect Immun; 1994 Jan; 62(1):15-23. PubMed ID: 8262621
[TBL] [Abstract][Full Text] [Related]
6. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
Wu HY; Russell MW
Infect Immun; 1993 Jan; 61(1):314-22. PubMed ID: 8418053
[TBL] [Abstract][Full Text] [Related]
7. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.
Russell MW; Moldoveanu Z; White PL; Sibert GJ; Mestecky J; Michalek S M
Infect Immun; 1996 Apr; 64(4):1272-83. PubMed ID: 8606090
[TBL] [Abstract][Full Text] [Related]
8. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.
Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR
J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444
[TBL] [Abstract][Full Text] [Related]
9. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.
Challacombe SJ; Rahman D; Jeffery H; Davis SS; O'Hagan DT
Immunology; 1992 May; 76(1):164-8. PubMed ID: 1628895
[TBL] [Abstract][Full Text] [Related]
10. Systemic and mucosal antibody responses to group B streptococci following immunization of the colonic-rectal mucosa.
Hordnes K; Digranes A; Haugen IL; Helland DE; Ulstein M; Jonsson R; Haneberg B
J Reprod Immunol; 1995 Mar; 28(3):247-62. PubMed ID: 7473434
[TBL] [Abstract][Full Text] [Related]
11. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY
J Immunol; 1996 Jun; 156(11):4290-7. PubMed ID: 8666800
[TBL] [Abstract][Full Text] [Related]
12. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.
Russell MW; Wu HY
Infect Immun; 1991 Nov; 59(11):4061-70. PubMed ID: 1937766
[TBL] [Abstract][Full Text] [Related]
13. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
[TBL] [Abstract][Full Text] [Related]
14. Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity.
Smith DJ; Lam A; Barnes LA; King WF; Peacock Z; Wise DL; Trantolo DJ; Taubman MA
Oral Microbiol Immunol; 2003 Aug; 18(4):240-8. PubMed ID: 12823800
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.
Qadri F; Ryan ET; Faruque AS; Ahmed F; Khan AI; Islam MM; Akramuzzaman SM; Sack DA; Calderwood SB
Infect Immun; 2003 Aug; 71(8):4808-14. PubMed ID: 12874365
[TBL] [Abstract][Full Text] [Related]
17. Transcutaneous immunization with phosphorylcholine induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
Nagano H; Kurono Y
Auris Nasus Larynx; 2015 Dec; 42(6):478-82. PubMed ID: 26092312
[TBL] [Abstract][Full Text] [Related]
18. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
[TBL] [Abstract][Full Text] [Related]
19. The identification of plant lectins with mucosal adjuvant activity.
Lavelle EC; Grant G; Pusztai A; Pfüller U; O'Hagan DT
Immunology; 2001 Jan; 102(1):77-86. PubMed ID: 11168640
[TBL] [Abstract][Full Text] [Related]
20. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
